Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease
ACS Nano · 21.05.2024 · 18 (20) · 12917-12932
DOI: 10.1021/acsnano.4c00830 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 09.05.2024. Verfasst von Qinglian Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China. Hauptthemen laut MEDLINE: Probiotics, Polyphenols, Nanoparticles, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China.
ORCID-Profile: Qinglian Hu, Yuanxiang Jin
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Hu, Q., Li, J., Wang, T., Xu, X., Duan, Y., & Jin, Y. (2024). Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease. ACS Nano, 18(20), 12917-12932. https://doi.org/10.1021/acsnano.4c00830
Vancouver
Hu Q, Li J, Wang T, Xu X, Duan Y, Jin Y. Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease. ACS Nano. 2024;18(20):12917-12932. doi:10.1021/acsnano.4c00830
BibTeX
@article{Hu2024,
author = {Hu, Qinglian and Li, Jingyu and Wang, Tong and Xu, Xiangchi and Duan, Yuxuan and Jin, Yuanxiang},
title = {Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {20},
pages = {12917--12932},
doi = {10.1021/acsnano.4c00830}
}
EUVIMED